Innovent Biologics (suzhou) Co. Ltd.

This is an early-stage study to find a safe dose of a new experimental drug called IBI363. It is for adults with advanced solid tumors or lymphomas that have not responded to other available treatments. The main goal is to check the drug's safety and side effects in a small group…

This study is testing if a new weekly injection called IBI362 works better than an existing drug, semaglutide, for people with early type 2 diabetes and obesity. About 349 Chinese adults will receive one of the two injections for 32 weeks to see which one helps more people reach …

This study is testing a new drug called IBI362 to see if it is safe and how it affects the body in people with moderate to severe obesity. It involves 98 Chinese adults and compares the new drug to a placebo (inactive substance) and another weight-loss medication. The main goals …